- Q1 2024 AstraZeneca PLC Earnings Call TranscriptApr 25, 2024MXN1294.72 (+6.68%)Earnings
- AstraZeneca PLC Sustainability 2023 Highlights Summary Call TranscriptMar 22, 2024
- Q4 2023 AstraZeneca PLC Earnings Call TranscriptFeb 08, 2024MXN1098 (-3.57%)Earnings
- AstraZeneca PLC at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Q3 2023 AstraZeneca PLC Earnings Call TranscriptNov 09, 2023MXN1130.3 (+2.12%)Earnings
- Q2 2023 AstraZeneca PLC Earnings Call TranscriptJul 28, 2023MXN1188.25 (+2.00%)Earnings
- AstraZeneca PLC at ASCO Investor Meeting (Virtual) TranscriptJun 05, 2023
- Q1 2023 AstraZeneca PLC Earnings Call TranscriptApr 27, 2023MXN1330.15 (-0.36%)Earnings
- Q4 2022 AstraZeneca PLC Earnings Call TranscriptFeb 09, 2023MXN1299.79 (+6.19%)Earnings
- Q4 2022 AstraZeneca PLC Earnings Presentation (Pre-Recorded) TranscriptFeb 09, 2023
- Q3 2022 AstraZeneca PLC Earnings Presentation TranscriptNov 10, 2022
- Q2 2022 AstraZeneca PLC Earnings Call TranscriptJul 29, 2022MXN1353 (-0.44%)Earnings
- AstraZeneca PLC Meet AZN management: American Society of Clinical Oncology 2022 Annual Meeting TranscriptJun 06, 2022
- Q1 2022 AstraZeneca PLC Earnings Call TranscriptApr 29, 2022MXN1358.51 (-0.39%)Earnings
- AstraZeneca PLC Investor Science Conference Call: ASCO GU 2022 TranscriptFeb 23, 2022
- Full Year 2021 AstraZeneca PLC Earnings Call TranscriptFeb 10, 2022MXN1150Earnings
- AstraZeneca PLC Investor science conference call: ASCO GI 2022 TranscriptJan 24, 2022
- AstraZeneca PLC at OTC Markets and Deutsche Bank Depositary Receipts Virtual Investor Conference TranscriptNov 17, 2021
- Q3 2021 AstraZeneca PLC Earnings Call TranscriptNov 12, 2021MXN1209 (-7.00%)Earnings
- AstraZeneca PLC ESMO Investor Science Conference Call TranscriptSep 20, 2021
- Q2 2021 AstraZeneca PLC Earnings Call TranscriptJul 29, 2021MXN1144 (+0.73%)Earnings
- AstraZeneca PLC Meet AZN Management: Oncology - 2021 ASCO Annual Meeting TranscriptJun 07, 2021
- Q1 2021 AstraZeneca PLC Earnings Call TranscriptApr 30, 2021MXN1074 (+4.27%)Earnings
- AstraZeneca PLC BioPharmaceuticals Virtual Event - New CVRM: Emerging Pipeline TranscriptMar 25, 2021
- AstraZeneca PLC BioPharmaceuticals Virtual Event - Opening and Q&A Session TranscriptMar 25, 2021
- Full Year 2020 AstraZeneca PLC Earnings Call TranscriptFeb 11, 2021MXN995 (-0.81%)Earnings
- AstraZeneca PLC to Acquire Alexion Pharmaceuticals Inc Call TranscriptDec 12, 2020
- Q3 2020 AstraZeneca PLC Earnings Call TranscriptNov 05, 2020MXN1141.41 (-0.32%)Earnings
- AstraZeneca PLC Investor Conference Call: Farxiga's DAPA-CKD Trial at ESC 2020 TranscriptAug 30, 2020
- Q2 2020 AstraZeneca PLC Earnings Call TranscriptJul 30, 2020MXN1280 (+2.89%)Earnings
- AstraZeneca PLC at ASCO Virtual Scientific Program TranscriptJun 01, 2020
- Q1 2020 AstraZeneca PLC Earnings Call TranscriptApr 29, 2020MXN1229Earnings
- Silence Therapeutics PLC Collaboration With AstraZeneca and R&D Update Call TranscriptMar 25, 2020
- Full Year 2019 AstraZeneca PLC Earnings Call TranscriptFeb 14, 2020MXN890 (-3.26%)Earnings
- AstraZeneca PLC Investor Science Conference Call - ASH 2019 TranscriptDec 10, 2019
- AstraZeneca PLC Investor Science Conference Call - ACR 2019 TranscriptNov 13, 2019
- AstraZeneca PLC Investor Science Conference Call - ASN 2019 TranscriptNov 10, 2019
- Q3 2019 AstraZeneca PLC Earnings Call TranscriptOct 24, 2019MXN852Earnings
- AstraZeneca PLC Investor Science Conference Call: ESMO 2019 TranscriptSep 30, 2019
- AstraZeneca PLC Investor Science Conference Call: Farxiga's DAPA-HF trial at ESC TranscriptSep 01, 2019
- Q2 2019 AstraZeneca PLC Earnings Call TranscriptJul 25, 2019MXN815 (+6.82%)Earnings
- AstraZeneca PLC at ASCO Annual Meeting TranscriptJun 03, 2019
- AstraZeneca PLC Annual Shareholders Meeting TranscriptApr 26, 2019
- Q1 2019 AstraZeneca PLC Earnings Call TranscriptApr 26, 2019MXN717 (-3.52%)Earnings
- AstraZeneca PLC to Discuss Strategic Collaboration in Oncology of Trastuzumab Deruxtecan (DS-8201) with Daiichi Sankyo Co Ltd Call TranscriptMar 29, 2019
- Daiichi Sankyo Co Ltd and AstraZeneca PLC DS-8201 Strategic Collaboration Presentation TranscriptMar 29, 2019
- Full Year 2018 AstraZeneca PLC Earnings Call TranscriptFeb 14, 2019MXN728.54Earnings
AstraZeneca PLC BioPharmaceuticals Virtual Event - New CVRM: Emerging Pipeline Transcript
Think we can start. Hi, and welcome, everyone. Today's breakout session (inaudible), called New CVRM: Emerging Pipeline. I'm Thomas Larsen from AstraZeneca the Investor Relations team, and I will be the moderator to for this breakout session.
With me today, I have members from our bio-pharmaceutical team. We have Regina Fritsche Danielson, Senior VP for the early stage R&D. We have Tomas Andersson, VP late-stage R&D, and we have Lori Kreamer, VP, CRM biopharmaceuticals business unit.
This breakout session will last around 30 minutes, there will be a short presentation, followed by Q&A. As usual, the presentations are available on astrazeneca.com/investors, and we also sent the presentations to people on our distribution list.
Before I hand over to today's presenter, I would like to remind you that this meeting is being recorded, and that this event is for [south] side analysts and institutional investors only.
To ask a question in the webinar, please raise your hand using the icon on the menu bar. We will then open up your
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)